HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
NDUFAF6
NADH:ubiquinone oxidoreductase complex assembly factor 6
Chromosome 8 Β· 8q22.1
NCBI Gene: 137682Ensembl: ENSG00000156170.14HGNC: HGNC:28625UniProt: A0A075B6P0
27PubMed Papers
22Diseases
0Drugs
34Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
mitochondrial respiratory chain complex I assemblymitochondrionmitochondrial inner membranenucleusLeigh syndromemitochondrial complex I deficiency, nuclear type 17mitochondrial complex I deficiencyprimary Fanconi syndrome
✦AI Summary

NDUFAF6 is a mitochondrial assembly factor essential for complex I biogenesis. It facilitates the incorporation of the NDUFS8 subunit into NADH:ubiquinone oxidoreductase complex I during early assembly stages 1. Loss of NDUFAF6 function results in reduced complex I activity and assembly in patient-derived fibroblasts 2. NDUFAF6 mutations cause mitochondrial complex I deficiency with severe neurological consequences. Biallelic NDUFAF6 mutations are associated with Leigh syndrome presenting as early-onset progressive dystonia with bilateral striatal necrosis and basal ganglia degeneration 2. NDUFAF6 variants also cause Fanconi renotubular syndrome 5, a generalized proximal tubular dysfunction disorder 3. A common NDUFAF6 polymorphism (rs6982393) shows age-dependent associations with Alzheimer's disease risk in elderly populations, with TT genotype carriers aged 60-69 showing increased AD susceptibility, particularly when combined with APOE Ξ΅4 4. In cancer biology, NDUFAF6 overexpression promotes breast cancer progression through mitochondrial dysfunction-related mechanisms; knockdown enhances apoptosis and mitophagy via impaired oxidative phosphorylation and increased reactive oxygen species 56. NDUFAF6 represents a critical hub linking mitochondrial energy metabolism to neurodegeneration and cancer pathogenesis.

Sources cited
1
NDUFAF6 facilitates NDUFS8 incorporation into complex I during assembly
PMID: 38720117
2
NDUFAF6 mutations cause Leigh syndrome with dystonia and bilateral striatal necrosis; mutations reduce complex I activity and assembly
PMID: 30642748
3
NDUFAF6 variants cause Fanconi renotubular syndrome 5
PMID: 38042745
4
NDUFAF6 rs6982393 TT genotype associates with increased Alzheimer's disease risk, particularly in ages 60-69 and combined with APOE Ξ΅4
PMID: 35237031
5
NDUFAF6 knockdown in breast cancer cells enhances apoptosis and mitophagy with mitochondrial dysfunction and increased ROS
PMID: 39706687
6
NDUFAF6 overexpression correlates with worse breast cancer prognosis and promotes PD-L1 expression by inhibiting NRF2 signaling
PMID: 38459583
Disease Associationsβ“˜22
Leigh syndromeOpen Targets
0.69Moderate
mitochondrial complex I deficiency, nuclear type 17Open Targets
0.68Moderate
mitochondrial complex I deficiencyOpen Targets
0.67Moderate
primary Fanconi syndromeOpen Targets
0.60Moderate
genetic disorderOpen Targets
0.49Moderate
neurodegenerative diseaseOpen Targets
0.48Moderate
mitochondrial diseaseOpen Targets
0.46Moderate
Fanconi renotubular syndrome 1Open Targets
0.37Weak
coronary artery diseaseOpen Targets
0.30Weak
Developmental regressionOpen Targets
0.30Weak
type 2 diabetes mellitusOpen Targets
0.29Weak
hypertensionOpen Targets
0.21Weak
diabetes mellitusOpen Targets
0.20Weak
essential hypertensionOpen Targets
0.19Weak
cardiovascular diseaseOpen Targets
0.14Weak
Alzheimer diseaseOpen Targets
0.12Weak
mitochondrial complex I deficiency, nuclear type 1Open Targets
0.11Weak
breast cancerOpen Targets
0.10Suggestive
keratoconusOpen Targets
0.08Suggestive
response to xenobiotic stimulusOpen Targets
0.07Suggestive
Fanconi renotubular syndrome 5UniProt
Mitochondrial complex I deficiency, nuclear type 17UniProt
Pathogenic Variants34
NM_152416.4(NDUFAF6):c.420+784C>TPathogenic
Mitochondrial complex I deficiency, nuclear type 17|not provided
β˜…β˜…β˜†β˜†2025
NM_152416.4(NDUFAF6):c.337C>T (p.Arg113Ter)Pathogenic
Leigh syndrome|not provided|Mitochondrial complex I deficiency, nuclear type 17|Familial prostate cancer
β˜…β˜…β˜†β˜†2025β†’ Residue 113
NM_152416.4(NDUFAF6):c.559_563del (p.Tyr187fs)Pathogenic
not provided|Mitochondrial complex I deficiency, nuclear type 17
β˜…β˜…β˜†β˜†2024β†’ Residue 187
NM_152416.4(NDUFAF6):c.29G>A (p.Trp10Ter)Pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 10
NM_152416.4(NDUFAF6):c.485del (p.Asn162fs)Pathogenic
Mitochondrial complex I deficiency, nuclear type 17|not provided|Mitochondrial complex I deficiency, nuclear type 17;Fanconi renotubular syndrome 5
β˜…β˜…β˜†β˜†2024β†’ Residue 162
NM_152416.4(NDUFAF6):c.561C>G (p.Tyr187Ter)Pathogenic
not provided|Inborn genetic diseases
β˜…β˜…β˜†β˜†2023β†’ Residue 187
NM_152416.4(NDUFAF6):c.2T>C (p.Met1Thr)Likely pathogenic
not provided|Inborn genetic diseases
β˜…β˜…β˜†β˜†2023β†’ Residue 1
NM_152416.4(NDUFAF6):c.322del (p.Thr108fs)Likely pathogenic
Mitochondrial complex I deficiency, nuclear type 17
β˜…β˜†β˜†β˜†2025β†’ Residue 108
NM_152416.4(NDUFAF6):c.648C>A (p.Cys216Ter)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 216
NM_152416.4(NDUFAF6):c.581-1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_152416.4(NDUFAF6):c.147_159del (p.Ser50fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 50
NM_152416.4(NDUFAF6):c.110_111del (p.Pro37fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 37
NM_152416.4(NDUFAF6):c.151G>T (p.Gly51Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 51
NM_152416.4(NDUFAF6):c.485_492dup (p.Asp165fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 165
NM_152416.4(NDUFAF6):c.536A>G (p.Glu179Gly)Likely pathogenic
Mitochondrial complex I deficiency, nuclear type 17
β˜…β˜†β˜†β˜†2024β†’ Residue 179
NM_152416.4(NDUFAF6):c.187G>T (p.Glu63Ter)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 63
NM_152416.4(NDUFAF6):c.198-2A>CLikely pathogenic
Mitochondrial complex I deficiency, nuclear type 17
β˜…β˜†β˜†β˜†2023
NM_152416.4(NDUFAF6):c.1A>C (p.Met1Leu)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 1
NM_152416.4(NDUFAF6):c.328G>T (p.Gly110Ter)Likely pathogenic
Mitochondrial complex I deficiency, nuclear type 17;Fanconi renotubular syndrome 5
β˜…β˜†β˜†β˜†2023β†’ Residue 110
NM_152416.4(NDUFAF6):c.719G>T (p.Gly240Val)Likely pathogenic
Leigh syndrome
β˜…β˜†β˜†β˜†2022β†’ Residue 240
View on ClinVar β†—
Related Genes
LYRM2Shared pathway100%DMAC1Shared pathway100%NDUFAF8Shared pathway100%NDUFS6Protein interaction100%NDUFB3Protein interaction100%NDUFAB1Protein interaction100%
Tissue Expression6 tissues
Bone Marrow
100%
Liver
66%
Heart
50%
Brain
47%
Ovary
37%
Lung
26%
Gene Interaction Network
Click a node to explore
NDUFAF6LYRM2DMAC1NDUFAF8NDUFS6NDUFB3NDUFAB1
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q330K2
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.57LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF1.19 [0.92–1.57]
RankingsWhere NDUFAF6 stands among ~20K protein-coding genes
  • #12,616of 20,598
    Most Researched27
  • #1,711of 5,498
    Most Pathogenic Variants34
  • #15,508of 17,882
    Most Constrained (LOEUF)1.57
Genes detectedNDUFAF6
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D.
PMID: 28965825
Cell Metab Β· 2017
1.00
2
Systematic analysis of NDUFAF6 in complex I assembly and mitochondrial disease.
PMID: 38720117
Nat Metab Β· 2024
0.90
3
A mitochondrial protein compendium elucidates complex I disease biology.
PMID: 18614015
Cell Β· 2008
0.80
4
Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis.
PMID: 39706687
Cancer Biol Ther Β· 2025
0.70
5
Mutations in the mitochondrial complex I assembly factor NDUFAF6 cause isolated bilateral striatal necrosis and progressive dystonia in childhood.
PMID: 30642748
Mol Genet Metab Β· 2019
0.60